Ashland INC Form 4 insider transactions

NYSE
Ashland Inc.'s SVP, CFO & PFO, William Whitaker, reported the acquisition of 107 common shares through RSU vesting and the disposition of 33 shares for tax purposes.
NYSE
Ashland's SVP, General Counsel, and Secretary, Robin E. Lampkin, reported the vesting of Restricted Stock Units and subsequent common stock transactions.
NYSE
Ashland Inc.'s SVP, General Counsel, and Secretary, Robin E. Lampkin, reported the exercise of Restricted Stock Units and subsequent tax-related share dispositions.
NYSE
Ashland Inc. CEO Guillermo Novo reported recent transactions involving common stock and Restricted Stock Units, including vesting and tax-related dispositions.
NYSE
Ashland Inc.'s SVP and Chief HRO, Eileen Drury, reported the exercise of restricted stock units and subsequent tax-related dispositions of common stock in mid-November 2025.
NYSE
Ashland SVP James P. Minicucci reported the acquisition of common stock through RSU vesting and subsequent tax-related dispositions.
NYSE
Ashland's SVP and GM of Life Sciences, Alessandra Faccin Assis, reported the acquisition of common stock and the disposition of shares for tax purposes related to Restricted Stock Units.
NYSE
Ashland SVP Dago Caceres reported the vesting of Restricted Stock Units, acquiring 746 shares and disposing of 215 for tax obligations.
NYSE
Ashland Inc.'s SVP, CFO & PFO, William Whitaker, reported the exercise of Restricted Stock Units and subsequent tax-related share disposals on November 13 and 14, 2025.
NYSE
Ashland Inc.'s VP, Controller, and PAO, Samuel Richardson, reported the acquisition and disposal of common stock related to Restricted Stock Unit vesting.
NYSE
Ashland Inc. Director Steven D. Bishop acquired 522 common stock units through a deferred compensation plan, increasing his beneficial ownership to 4,362 units.
NYSE
Ashland Inc. Director Sanat Chattopadhyay acquired 300 Common Stock Units through the company's deferred compensation plan, increasing his beneficial ownership to 1,425 units.
NYSE
Alessandra Faccin Assis, SVP and GM of Life Sciences at Ashland Inc., reported the exercise of restricted stock units and the sale of shares to cover tax obligations.
NYSE
Ashland Inc.'s SVP, CFO & PFO, William Whitaker, was granted 8,620 Restricted Stock Units, vesting in three annual installments starting November 2026.
NYSE
Ashland Inc. Director Steven D. Bishop has acquired 497 Common Stock Units at a price of $50.28 per unit through the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Ashland Inc. Director Sanat Chattopadhyay acquired 286 Common Stock Units at a price of $50.28 per unit through the company's Deferred Compensation Plan, increasing his direct beneficial ownership to 1,116 units.
NYSE
VP, Controller and PAO of Ashland Inc., Samuel Richardson, reports the acquisition of 2,516 Restricted Stock Units (RSUs) on May 15, 2025, under the company's incentive plan.
NYSE
William Whitaker, Interim CFO and PFO of Ashland Inc., was granted 2,516 Restricted Stock Units (RSUs) on May 15, 2025, under the company's incentive plan.
NYSE
James P. Minicucci, SVP and GM of Personal Care at Ashland Inc., reports the vesting and subsequent tax withholding of restricted stock units.
NYSE
Director Ashish K. Kulkarni reports the vesting of restricted stock units into Ashland Inc. common stock.
NYSE
Director Sanat Chattopadhyay reports acquiring 235 common stock units of Ashland Inc. through the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Steven D. Bishop reports acquiring 422 common stock units of Ashland Inc. through the company's Deferred Compensation Plan for Non-Employee Directors.
NYSE
Ashland Inc.'s CEO, Guillermo Novo, acquired 31,294 shares of common stock through a family limited partnership on January 31, 2025.
NYSE
Alessandra Faccin Assis, SVP and GM of Life Sciences at Ashland Inc., recently acquired 3,150 shares of common stock.
NYSE
Director Suzan F. Harrison reports the vesting of 1,931 restricted stock units into common stock on January 23, 2025.
NYSE
Director Steven D. Bishop reports acquiring 2,050 restricted stock units (RSUs) of Ashland Inc. on January 21, 2025.
NYSE
Director Suzan F. Harrison reports acquiring 2,050 Restricted Stock Units (RSUs) of Ashland Inc. on January 21, 2025, under the company's Omnibus Incentive Plan.
NYSE
Director Sue Main reports acquiring 2,050 restricted stock units (RSUs) of Ashland Inc. on January 21, 2025.
NYSE
Director Sergio Pedreiro reports acquisition of 2,050 restricted stock units in Ashland Inc.
NYSE
Director Jerome Peribere reports acquisition of 2,050 Restricted Stock Units (RSUs) in Ashland Inc. under the company's Omnibus Incentive Plan.